CELL INTELLIGENCE · 肿瘤细胞治疗研究

嵌合抗原受体自然杀伤（CAR-NK）细胞治疗乳腺癌的疗效与安全性评价：系统综述与荟萃分析

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.

CAR-T 细胞治疗与外周实体瘤重建性肿瘤外科手术：叙述性综述

CAR-T cell therapy and reconstructive oncologic surgery in peripheral solid tumors-A narrative review.

通过 TRAIL 受体 2 选择性靶向髓源性抑制细胞以增强 CAR-T 细胞治疗乳腺癌的疗效

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast

我们的研究结果表明，共表达 TR2.4-1BB 受体的 CAR-T 细胞对含有免疫抑制和促肿瘤 MDSC 的乳腺肿瘤表现出更强的抗肿瘤潜力，从而导致 TME 重塑并改善肿瘤部位的 T 细胞增殖。